Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
1.
Acta Neuropathol ; 142(6): 985-1001, 2021 12.
Article in English | MEDLINE | ID: mdl-34618203

ABSTRACT

Amyotrophic lateral sclerosis is a progressive fatal neurodegenerative disease caused by loss of motor neurons and characterized neuropathologically in almost all cases by nuclear depletion and cytoplasmic aggregation of TDP-43, a nuclear RNA-binding protein (RBP). We identified ELAVL3 as one of the most downregulated genes in our transcriptome profiles of laser captured microdissection of motor neurons from sporadic ALS nervous systems and the most dysregulated of all RBPs. Neuropathological characterizations showed ELAVL3 nuclear depletion in a great percentage of remnant motor neurons, sometimes accompanied by cytoplasmic accumulations. These abnormalities were common in sporadic cases with and without intermediate expansions in ATXN2 and familial cases carrying mutations in C9orf72 and SOD1. Depletion of ELAVL3 occurred at both the RNA and protein levels and a short protein isoform was identified, but it is not related to a TDP-43-dependent cryptic exon in intron 3. Strikingly, ELAVL3 abnormalities were more frequent than TDP-43 abnormalities and occurred in motor neurons still with normal nuclear TDP-43 present, but all neurons with abnormal TDP-43 also had abnormal ELAVL3. In a neuron-like cell culture model using SH-SY5Y cells, ELAVL3 mislocalization occurred weeks before TDP-43 abnormalities were seen. We interrogated genetic databases, but did not identify association of ELAVL3 genetic structure with ALS. Taken together, these findings suggest that ELAVL3 is an important RBP in ALS pathogenesis acquired early and the neuropathological data suggest that it is involved by loss of function rather than cytoplasmic toxicity.


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , Amyotrophic Lateral Sclerosis/pathology , ELAV-Like Protein 3/metabolism , Motor Neurons/metabolism , Cell Nucleus/metabolism , Humans
2.
Am J Pathol ; 191(10): 1837-1850, 2021 10.
Article in English | MEDLINE | ID: mdl-34214505

ABSTRACT

Deregulated full-length anaplastic lymphoma kinase (ALK) overexpression has been found in some primary solid tumors, but little is known about its role in ovarian high-grade serous carcinoma (HGSC). The current study focused on the functional roles of ALK in HGSC. Cytoplasmic ALK immunoreactivity without chromosomal rearrangement and gene mutations was significantly higher in HGSC compared with non-HGSC-type ovarian carcinomas, and was significantly associated with several unfavorable clinicopathologic factors and poor prognosis. HGSC cell lines stably overexpressing ALK exhibited increased cell proliferation, enhanced cancer stem cell features, and accelerated cell mobility, whereas these phenotypes were abrogated in ALK-knockdown cells. Expression of the nervous system-associated gene, ELAVL3, and the corresponding protein (commonly known as HuC) was significantly increased in cells overexpressing ALK. Expression of SRY-box transcription factor (Sox)2 and Sox3 (genes associated with the neural progenitor population) increased in ALK-overexpressing but not ALK-knockdown cells. Furthermore, overexpression of Sox2 or Sox3 enhanced both ALK and ELAVL3 promoter activities, suggesting the existence of ALK/Sox/HuC signaling loops. Finally, ALK overexpression was attributed to increased expression of neuroendocrine markers, including synaptophysin, CD56, and B-cell lymphoma 2, in HGSC tissues. These findings suggest that overexpression of full-length ALK may influence the biological behavior of HGSC through cooperation with ELAVL3 and Sox factors, leading to the establishment and maintenance of the aggressive phenotypic characteristics of HGSC.


Subject(s)
Anaplastic Lymphoma Kinase/metabolism , Cystadenocarcinoma, Serous/enzymology , Cystadenocarcinoma, Serous/pathology , Ovarian Neoplasms/enzymology , Ovarian Neoplasms/pathology , Adult , Aged , Cell Differentiation , Cell Line, Tumor , Cell Movement , Cell Proliferation , Cytoplasm/enzymology , ELAV-Like Protein 3/metabolism , Female , Humans , Middle Aged , Models, Biological , Multivariate Analysis , Neoplasm Grading , Neoplastic Stem Cells/pathology , Neuroendocrine Cells/metabolism , Neuroendocrine Cells/pathology , Phenotype , Prognosis , Progression-Free Survival , SOX Transcription Factors/metabolism
3.
Stem Cells ; 39(4): 458-466, 2021 04.
Article in English | MEDLINE | ID: mdl-33442906

ABSTRACT

Development of the retina is regulated by growth factors, such as insulin-like growth factors 1 and 2 (IGF-1/2), which coordinate proliferation, differentiation, and maturation of the neuroepithelial precursors cells. In the circulation, IGF-1/2 are transported by the insulin growth factor binding proteins (IGFBPs) family members. IGFBPs can impact positively and negatively on IGF-1, by making it available or sequestering IGF-1 to or from its receptor. In this study, we investigated the expression of IGFBPs and their role in the generation of human retinal organoids from human pluripotent stem cells, showing a dynamic expression pattern suggestive of different IGFBPs being used in a stage-specific manner to mediate IGF-1 functions. Our data show that IGF-1 addition to culture media facilitated the generation of retinal organoids displaying the typical laminated structure and photoreceptor maturation. The organoids cultured in the absence of IGF-1, lacked the typical laminated structure at the early stages of differentiation and contained significantly less photoreceptors and more retinal ganglion cells at the later stages of differentiation, confirming the positive effects of IGF-1 on retinal lamination and photoreceptor development. The organoids cultured with the IGFBP inhibitor (NBI-31772) and IGF-1 showed lack of retinal lamination at the early stages of differentiation, an increased propensity to generate horizontal cells at mid-stages of differentiation and reduced photoreceptor development at the later stages of differentiation. Together these data suggest that IGFBPs enable IGF-1's role in retinal lamination and photoreceptor development in a stage-specific manner.


Subject(s)
Insulin-Like Growth Factor Binding Proteins/genetics , Insulin-Like Growth Factor II/genetics , Insulin-Like Growth Factor I/genetics , Organoids/metabolism , Photoreceptor Cells, Vertebrate/metabolism , Pluripotent Stem Cells/metabolism , Catechols/pharmacology , Cell Differentiation/drug effects , ELAV-Like Protein 3/genetics , ELAV-Like Protein 3/metabolism , ELAV-Like Protein 4/genetics , ELAV-Like Protein 4/metabolism , Gene Expression Regulation , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Humans , Insulin-Like Growth Factor Binding Proteins/antagonists & inhibitors , Insulin-Like Growth Factor Binding Proteins/metabolism , Insulin-Like Growth Factor I/metabolism , Insulin-Like Growth Factor I/pharmacology , Insulin-Like Growth Factor II/metabolism , Isoquinolines/pharmacology , Ki-67 Antigen/genetics , Ki-67 Antigen/metabolism , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Organoids/cytology , Organoids/drug effects , Photoreceptor Cells, Vertebrate/cytology , Photoreceptor Cells, Vertebrate/drug effects , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/drug effects , Recoverin/genetics , Recoverin/metabolism , Signal Transduction , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , gamma-Synuclein/genetics , gamma-Synuclein/metabolism
4.
EMBO J ; 39(12): e103558, 2020 06 17.
Article in English | MEDLINE | ID: mdl-32395844

ABSTRACT

Noise is prevalent in biology and has been widely quantified using snapshot measurements. This static view obscures our understanding of dynamic noise properties and how these affect gene expression and cell state transitions. Using a CRISPR/Cas9 Zebrafish her6::Venus reporter combined with mathematical and in vivo experimentation, we explore how noise affects the protein dynamics of Her6, a basic helix-loop-helix transcriptional repressor. During neurogenesis, Her6 expression transitions from fluctuating to oscillatory at single-cell level. We identify that absence of miR-9 input generates high-frequency noise in Her6 traces, inhibits the transition to oscillatory protein expression and prevents the downregulation of Her6. Together, these impair the upregulation of downstream targets and cells accumulate in a normally transitory state where progenitor and early differentiation markers are co-expressed. Computational modelling and double smFISH of her6 and the early neurogenesis marker, elavl3, suggest that the change in Her6 dynamics precedes the downregulation in Her6 levels. This sheds light onto the order of events at the moment of cell state transition and how this is influenced by the dynamic properties of noise. Our results suggest that Her/Hes oscillations, facilitated by dynamic noise optimization by miR-9, endow progenitor cells with the ability to make a cell state transition.


Subject(s)
Animals, Genetically Modified/embryology , Basic Helix-Loop-Helix Transcription Factors/metabolism , Biological Clocks , MicroRNAs/metabolism , Neurogenesis , Zebrafish Proteins/metabolism , Zebrafish/embryology , Animals , Animals, Genetically Modified/genetics , Basic Helix-Loop-Helix Transcription Factors/genetics , ELAV-Like Protein 3/genetics , ELAV-Like Protein 3/metabolism , MicroRNAs/genetics , Zebrafish/genetics , Zebrafish Proteins/genetics
5.
Int J Mol Sci ; 20(8)2019 Apr 22.
Article in English | MEDLINE | ID: mdl-31013625

ABSTRACT

The neuron-specific Elav-like Hu RNA-binding proteins were described to play an important role in neuronal differentiation and plasticity by ensuring the post-transcriptional control of RNAs encoding for various proteins. Although Elav-like Hu proteins alterations were reported in diabetes or neuropathy, little is known about the regulation of neuron-specific Elav-like Hu RNA-binding proteins in sensory neurons of dorsal root ganglia (DRG) due to the diabetic condition. The goal of our study was to analyze the gene and protein expression of HuB, HuC, and HuD in DRG sensory neurons in diabetes. The diabetic condition was induced in CD-1 adult male mice with single-intraperitoneal injection of streptozotocin (STZ, 150 mg/kg), and 8-weeks (advanced diabetes) after induction was quantified the Elav-like proteins expression. Based on the glycemia values, we identified two types of responses to STZ, and mice were classified in STZ-resistant (diabetic resistant, glycemia < 260 mg/dL) and STZ-sensitive (diabetic, glycemia > 260 mg/dL). Body weight measurements indicated that 8-weeks after STZ-induction of diabetes, control mice have a higher increase in body weight compared to the diabetic and diabetic resistant mice. Moreover, after 8-weeks, diabetic mice (19.52 ± 3.52 s) have longer paw withdrawal latencies in the hot-plate test than diabetic resistant (11.36 ± 1.92 s) and control (11.03 ± 1.97 s) mice, that correlates with the installation of warm hypoalgesia due to the diabetic condition. Further on, we evidenced the decrease of Elav-like gene expression in DRG neurons of diabetic mice (Elavl2, 0.68 ± 0.05 fold; Elavl3, 0.65 ± 0.01 fold; Elavl4, 0.53 ± 0.07 fold) and diabetic resistant mice (Ealvl2, 0.56 ± 0.07 fold; Elavl3, 0.32 ± 0.09 fold) compared to control mice. Interestingly, Elav-like genes have a more accentuated downregulation in diabetic resistant than in diabetic mice, although hypoalgesia was evidenced only in diabetic mice. The Elav-like gene expression changes do not always correlate with the Hu protein expression changes. To detail, HuB is upregulated and HuD is downregulated in diabetic mice, while HuB, HuC, and HuD are downregulated in diabetic resistant mice compared to control mice. To resume, we demonstrated HuD downregulation and HuB upregulation in DRG sensory neurons induced by diabetes, which might be correlated with altered post-transcriptional control of RNAs involved in the regulation of thermal hypoalgesia condition caused by the advanced diabetic neuropathy.


Subject(s)
ELAV-Like Protein 2/genetics , ELAV-Like Protein 3/genetics , ELAV-Like Protein 4/genetics , Ganglia, Spinal/cytology , Ganglia, Spinal/metabolism , Gene Expression Regulation , Sensory Receptor Cells/metabolism , Animals , Biomarkers , Blood Glucose , Body Weight , Diabetes Mellitus, Experimental , ELAV-Like Protein 2/metabolism , ELAV-Like Protein 3/metabolism , ELAV-Like Protein 4/metabolism , Ganglia, Spinal/physiopathology , Immunohistochemistry , Mice , RNA-Binding Proteins
6.
Hum Pathol ; 85: 162-167, 2019 03.
Article in English | MEDLINE | ID: mdl-30468801

ABSTRACT

The RNA-binding protein HuC/D displays a neuron-specific expression and is involved in neuronal differentiation and the maintenance of the nervous system. Here we investigated the diagnostic value of HuC/D in neuroblastomas. We evaluated 85 neuroblastic tumors: 81 neuroblastomas; 3 ganglioneuroblastomas, intermixed; 1 ganglioneuroma, maturing; and 101 other tumors consisting of 34 Ewing sarcomas, 14 nephroblastomas, 11 rhabdomyosarcomas, 15 pulmonary small cell carcinomas, 18 pancreatic neuroendocrine tumors, and 9 pheochromocytomas. Immunohistochemistry for HuC/D, PHOX2B, and tyrosine hydroxylase was performed. The immunoreactivity for HuC/D was semiquantified using the total score (TS; range, 0-8). HuC/D positivity was defined as a TS ≥6. The TS of the neuroblastic tumors (mean TS, 7.94) was significantly higher than those of the other small round cell tumors and neuroendocrine tumors (P < .001) except for the pheochromocytomas (mean TS, 6.89; P = .074). HuC/D was positive in all 85 neuroblastic tumors, 1 (2.9%) Ewing sarcoma, 1 (6.7%) pulmonary small cell carcinoma, and 8 (89%) pheochromocytomas. PHOX2B was positive in all of the neuroblastic tumors and pheochromocytomas. Tyrosine hydroxylase was positive in 80 (94%) neuroblastic tumors, 1 (9.1%) rhabdomyosarcoma, and all of the pheochromocytomas. Therefore, HuC/D serves as a highly sensitive diagnostic marker to distinguish neuroblastomas from other small round cell tumors. The combination of HuC/D and PHOX2B staining may be valuable for the diagnosis of neuroblastic tumors, especially in the assessment of small sections. HuC/D expression in tumors may be related to catecholamine production or a neural crest-derived cell origin.


Subject(s)
Adrenal Gland Neoplasms/diagnosis , Carcinoma, Small Cell/diagnosis , ELAV-Like Protein 3/metabolism , Ganglioneuroblastoma/diagnosis , Neuroblastoma/diagnosis , Neuroendocrine Tumors/diagnosis , Pancreatic Neoplasms/diagnosis , Pheochromocytoma/diagnosis , Adolescent , Adrenal Gland Neoplasms/metabolism , Adrenal Gland Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Small Cell/metabolism , Carcinoma, Small Cell/pathology , Child , Child, Preschool , Diagnosis, Differential , Female , Ganglioneuroblastoma/metabolism , Ganglioneuroblastoma/pathology , Homeodomain Proteins/metabolism , Humans , Infant , Infant, Newborn , Male , Middle Aged , Neuroblastoma/metabolism , Neuroblastoma/pathology , Neuroendocrine Tumors/metabolism , Neuroendocrine Tumors/pathology , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/pathology , Pheochromocytoma/metabolism , Pheochromocytoma/pathology , Sensitivity and Specificity , Transcription Factors/metabolism , Young Adult
7.
Neuroreport ; 29(16): 1349-1354, 2018 11 07.
Article in English | MEDLINE | ID: mdl-30192301

ABSTRACT

Voltage-sensitive dye (VSD) imaging enables fast, direct, and simultaneous detection of membrane potentials from a population of neurons forming neuronal circuits. This enables the detection of hyperpolarization together with depolarization, whose balance plays a pivotal role in the function of many brain regions. Among these is the cerebellum, which contains a significant number of inhibitory neurons. However, the mechanism underlying the functional development remains unclear. In this study, we used a model system ideal to study neurogenesis by applying VSD imaging to the cerebellum of zebrafish larvae to analyze the neuronal activity of the developing cerebellum, focusing on both excitation and inhibition. We performed in-vivo high-speed imaging of the entire cerebellum of the zebrafish, which was stained using Di-4-ANEPPS, a widely used VSD. To examine whether neuronal activity in the zebrafish cerebellum could be detected by this VSD, we applied electrical stimulation during VSD imaging, which showed that depolarization was detected widely in the cerebellum upon stimulation. These responses mostly disappeared following treatment with tetrodotoxin, indicating that Di-4-ANEPPS enabled optical measurement of neuronal activity in the developing cerebellum of zebrafish. Moreover, hyperpolarizing signals were also detected upon stimulation, but these were significantly reduced by treatment with picrotoxin, a GABAA receptor inhibitor, indicating that these responses represent inhibitory signals. This approach will enable a detailed analysis of the spatiotemporal dynamics of the excitation and inhibition in the cerebellum along its developmental stages, leading to a deeper understanding of the functional development of the cerebellum in vertebrates.


Subject(s)
Cerebellum/cytology , Cerebellum/growth & development , Neurons/physiology , Voltage-Sensitive Dye Imaging/methods , Animals , Animals, Genetically Modified , ELAV-Like Protein 3/genetics , ELAV-Like Protein 3/metabolism , Electric Stimulation , GABA Antagonists/pharmacology , Larva , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Microscopy, Confocal , Neurons/drug effects , Picrotoxin/pharmacology , Pyridinium Compounds/metabolism , Sodium Channel Blockers/pharmacology , Tetrodotoxin/pharmacology , Zebrafish , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism , src-Family Kinases/genetics , src-Family Kinases/metabolism
8.
Neuropharmacology ; 135: 444-454, 2018 06.
Article in English | MEDLINE | ID: mdl-29626565

ABSTRACT

Currently available antidepressant drugs often fail to achieve full remission and patients might evolve to treatment resistance, showing the need to achieve a better therapy of depressive disorders. Increasing evidence supports that post-transcriptional regulation of gene expression is important in neuronal development and survival and a relevant role is played by RNA binding proteins (RBP). To explore new therapeutic strategies, we investigated the role of the neuron-specific ELAV-like RBP (HuB, HuC, HuD) in a mouse model of depression. In this study, a 4-week unpredictable chronic mild stress (UCMS) protocol was applied to mice to induce a depressive-like phenotype. In the last 2 weeks of the UCMS regimen, silencing of HuB, HuC or HuD was performed by using specific antisense oligonucleotides (aODN). Treatment of UCMS-exposed mice with anti-HuB and anti-HuC aODN improved both anhedonia and behavioural despair, used as measures of depressive-like behaviour, without modifying the response of stressed mice to an anxiety-inducing environment. On the contrary, HuD silencing promoted an anxiolytic-like behaviour in UCMS-exposed mice without improving depressive-like behaviours. The antidepressant-like phenotype of anti-HuB and anti-HuC mice was not shown concurrently with the promotion of adult hippocampal neurogenesis in the dentate gyrus, and no increase in the BDNF and CREB content was detected. Conversely, in the CA3 hippocampal region, projection area of newly born neurons, HuB and HuC silencing increased the number of BrdU/NeuN positive cells. These results give the first indication of a role of nELAV in the modulation of emotional states in a mouse model of depression.


Subject(s)
Antidepressive Agents/pharmacology , Depressive Disorder/drug therapy , ELAV-Like Protein 2/antagonists & inhibitors , ELAV-Like Protein 3/antagonists & inhibitors , Neurons/drug effects , Anhedonia/drug effects , Anhedonia/physiology , Animals , Anxiety/metabolism , Bromodeoxyuridine , DNA-Binding Proteins , Depressive Disorder/metabolism , Depressive Disorder/pathology , Disease Models, Animal , ELAV-Like Protein 2/metabolism , ELAV-Like Protein 3/metabolism , ELAV-Like Protein 4/antagonists & inhibitors , ELAV-Like Protein 4/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/pathology , Male , Mice , Nerve Tissue Proteins/metabolism , Neurogenesis/drug effects , Neurogenesis/physiology , Neurons/metabolism , Neurons/pathology , Nuclear Proteins/metabolism , Random Allocation
9.
Neurosci Res ; 135: 13-20, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29614249

ABSTRACT

Alternative splicing of RNAs diversifies the functionalities of proteins, and it is optimized for each cell type and each developmental stage. nElavl (composed of Elavl2, Elavl3, and Elavl4) proteins are the RNA-binding proteins that is specifically expressed in neurons, regulate the alternative splicing of target RNAs, and promote neuronal differentiation and maturation. Recent studies revealed that Elavl3 knockout (Elavl3-/-) mice completely lost the expression of nElavl proteins in the Purkinje cells and exhibited cerebellar dysfunction. Here, we found that the alternative splicing of AnkyrinG exon 34 was misregulated in the cerebella of Elavl3-/- mice. AnkyrinG is an essential factor for the formation of neuronal polarity and is required for normal neuronal functions. We revealed that exon 34 of AnkyrinG was normally included in immature neurons and was mostly excluded in mature neurons; however, it was included in the cerebella of Elavl3-/- mice even in adulthood. In the Purkinje cells of adult Elavl3-/- mice, the length of the AnkyrinG-positive region shortened and somatic organelles leaked into the axons. These results suggested that exon 34 of AnkyrinG is an embryonic-stage-preferential exon that should be excluded from mature neurons and that Elavl3 regulates neuronal polarity through alternative splicing of this exon.


Subject(s)
Ankyrins/genetics , ELAV-Like Protein 3/genetics , Exons , Purkinje Cells/physiology , Alternative Splicing , Amino Acid Sequence , Animals , Ankyrins/metabolism , Cell Polarity/genetics , Cerebellar Diseases/genetics , Cerebellar Diseases/metabolism , Cerebellar Diseases/pathology , Cerebellum/pathology , ELAV-Like Protein 3/metabolism , ELAV-Like Protein 3/ultrastructure , Mice , Mice, Inbred C57BL , Mice, Knockout , Purkinje Cells/cytology , Purkinje Cells/metabolism , Sequence Homology, Amino Acid
10.
Sci Rep ; 8(1): 3180, 2018 02 16.
Article in English | MEDLINE | ID: mdl-29453425

ABSTRACT

Gastrointestinal symptoms are the first signs of fluoride (F) toxicity. In the present study, the jejunum of rats chronically exposed to F was evaluated by proteomics, as well as by morphological analysis. Wistar rats received water containing 0, 10 or 50 mgF/L during 30 days. HuC/D, neuronal Nitric Oxide (nNOS), Vasoactive Intestinal Peptide (VIP), Calcitonin Gene Related Peptide (CGRP), and Substance P (SP) were detected in the myenteric plexus of the jejunum by immunofluorescence. The density of nNOS-IR neurons was significantly decreased (compared to both control and 10 mgF/L groups), while the VIP-IR varicosities were significantly increased (compared to control) in the group treated with the highest F concentration. Significant morphological changes were seen observed in the density of HUC/D-IR neurons and in the area of SP-IR varicosities for F-treated groups compared to control. Changes in the abundance of various proteins correlated with relevant biological processes, such as protein synthesis, glucose homeostasis and energy metabolism were revealed by proteomics.


Subject(s)
Fluorides/adverse effects , Jejunum/drug effects , Animals , Calcitonin Gene-Related Peptide/metabolism , Duodenum/metabolism , ELAV-Like Protein 3/metabolism , Enteric Nervous System/drug effects , Intestine, Small/metabolism , Male , Minerals/metabolism , Nitric Oxide/analysis , Nitric Oxide/metabolism , Proteomics/methods , Rats , Rats, Wistar , Substance P/metabolism , Vasoactive Intestinal Peptide/metabolism
11.
CNS Neurosci Ther ; 24(8): 721-733, 2018 08.
Article in English | MEDLINE | ID: mdl-29479825

ABSTRACT

AIMS: Serotonergic (5-HT) modulation of the lateral habenula (LHb) activity is central in normal and pathologic conditions such as mood disorders. Among the multiple 5-HT receptors (5-HTRs) involved, the 5-HT2C R seems to play a pivotal role. Yet, the role of 5-HT2A Rs in the control of the LHb neuronal activity is completely unknown. METHODS: Single-cell extracellular recording of the LHb neurons was used in rats to study the effect of the general activation and blockade of the 5-HT2C R and 5-HT2A R with Ro 60-0175 and SB242084, TCB-2 and MDL11939, respectively. The expression of both receptors in the LHb was confirmed using immunohistochemistry. RESULTS: Cumulative doses (5-640 µg/kg, iv) of Ro 60-0175 and TCB-2 affected the activity of 34% and 63% of the LHb recorded neurons, respectively. LHb neurons were either inhibited at low doses or excited at higher doses of the 5-HT2A/C R agonists. SB242084 or MDL11939 (both at 200 µg/kg, iv) did not modify neuronal firing when injected alone, but reverted the bidirectional effects of Ro 60-0175 or TCB-2, respectively. 5-HT2C Rs and 5-HT2A Rs are expressed in less than the 20% of the LHb neurons, and they neither colocalize nor make heterodimers. Strikingly, only 5-HT2A Rs are expressed by the majority of LHb astrocyte cells. CONCLUSIONS: Peripheral administration of 5-HT2A R agonist promotes a heterogeneous pattern of neuronal responses in the LHb, and these effects are more prominent than those induced by the 5-HT2C R activation.


Subject(s)
Action Potentials/drug effects , Habenula/cytology , Habenula/metabolism , Neurons/physiology , Receptor, Serotonin, 5-HT2A/metabolism , Receptor, Serotonin, 5-HT2C/metabolism , Animals , Dose-Response Relationship, Drug , ELAV-Like Protein 3/metabolism , Glutamate Decarboxylase/metabolism , Habenula/drug effects , Male , Nerve Tissue Proteins/metabolism , Neurons/drug effects , Patch-Clamp Techniques , Rats , Rats, Sprague-Dawley , Serotonin Agents/pharmacology
12.
Neurotoxicology ; 65: 111-124, 2018 03.
Article in English | MEDLINE | ID: mdl-29432853

ABSTRACT

The use of electronic cigarettes (e-cigarettes) is increasing despite insufficient information concerning their long-term effects, including the effects of maternal e-cigarette use on pre- and postnatal development. Our previous study demonstrated that developmental exposure to 1,2-propanediol (a principal component of e-cigarette liquid) affected early development of zebrafish, causing reduced growth, deformities, and hyperactive swimming behavior in larvae. The current study extends assessment of the developmental toxicity of 1,2-propanediol by examining additional long-term behavioral effects. We demonstrate that embryonic/larval exposure of zebrafish to 1,2-propanediol (0.625% or 1.25%) not only affected behavioral parameters in the larvae, but also caused persisting behavioral effects in adults after early developmental exposure. Additional parameters, including neural and vascular development in larvae, stress response in adults, and concentration of neurotransmitters dopamine and serotonin in adult brain were examined, in order to explain the behavioral differences. These additional assessments did not find 1,2-propanediol exposure to significantly affect Tg(Neurog1:GFP) or the transcript abundance of neural genes (Neurog1, Ascl1a, Elavl3, and Lef1). Vascular development was not found to be affected by 1,2-propanediol exposure, as inferred from experiments with Tg(Flk1:eGFP) zebrafish; however, transcript abundance of vascular genes (Flk1, Vegf, Tie-2, and Angpt1) was decreased. No statistically significant changes were noted for plasma cortisol or brain neurotransmitters in adult fish. Lastly, analysis of gene transcripts involved with 1,2-propanediol metabolism (Adh5, Aldh2.1, and Ldha) showed an increase in Adh5 transcript. This is the first study to demonstrate that developmental exposure to 1,2-propanediol has long-term neurobehavioral consequences in adult zebrafish, showing that e-cigarettes contain substances potentially harmful to neurodevelopment.


Subject(s)
Behavior, Animal/drug effects , Brain/metabolism , Gene Expression Regulation, Developmental/drug effects , Propylene Glycol/toxicity , Animals , Basic Helix-Loop-Helix Transcription Factors/metabolism , Blood Vessels/growth & development , Blood Vessels/metabolism , Dopamine/metabolism , ELAV-Like Protein 3/metabolism , Hydrocortisone/blood , Inactivation, Metabolic/genetics , Nerve Tissue Proteins/metabolism , Serotonin/metabolism , Transcription Factors/metabolism , Zebrafish , Zebrafish Proteins/metabolism
13.
J Comp Neurol ; 526(1): 133-145, 2018 Jan 01.
Article in English | MEDLINE | ID: mdl-28891045

ABSTRACT

In the developing hypothalamus, the fat-derived hormone leptin stimulates the growth of axons from the arcuate nucleus of the hypothalamus (ARH) to other regions that control energy balance. These projections are significantly reduced in leptin deficient (Lepob/ob ) mice and this phenotype is largely rescued by neonatal leptin treatments. However, treatment of mature Lepob/ob mice is ineffective, suggesting that the trophic action of leptin is limited to a developmental critical period. To temporally delineate closure of this critical period for leptin-stimulated growth, we treated Lepob/ob mice with exogenous leptin during a variety of discrete time periods, and measured the density of Agouti-Related Peptide (AgRP) containing projections from the ARH to the ventral part of the dorsomedial nucleus of the hypothalamus (DMHv), and to the medial parvocellular part of the paraventricular nucleus (PVHmp). The results indicate that leptin loses its neurotrophic potential at or near postnatal day 28. The duration of leptin exposure appears to be important, with 9- or 11-day treatments found to be more effective than shorter (5-day) treatments. Furthermore, leptin treatment for 9 days or more was sufficient to restore AgRP innervation to both the PVHmp and DMHv in Lepob/ob females, but only to the DMHv in Lepob/ob males. Together, these findings reveal that the trophic actions of leptin are contingent upon timing and duration of leptin exposure, display both target and sex specificity, and that modulation of leptin-dependent circuit formation by each of these factors may carry enduring consequences for feeding behavior, metabolism, and obesity risk.


Subject(s)
Agouti-Related Protein/metabolism , Arcuate Nucleus of Hypothalamus/cytology , Leptin/metabolism , Leptin/pharmacology , Neurons/drug effects , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Axons/drug effects , ELAV-Like Protein 3/metabolism , Estrogen Receptor alpha/metabolism , Female , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Integrases/genetics , Integrases/metabolism , Leptin/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neuropeptide Y/genetics , Neuropeptide Y/metabolism , Receptors, Leptin/genetics , Receptors, Leptin/metabolism , STAT3 Transcription Factor/metabolism
14.
Brain Struct Funct ; 223(1): 391-414, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28852859

ABSTRACT

Following fasting, satiety is accompanied by neuronal activation in brain areas including the central amygdalar nucleus (CEA). Since CEA is known to inhibit food intake, we hypothesized that CEA contributes to the termination of meal during refeeding. To better understand the organization of this satiety-related circuit, the interconnections of the CEA with refeeding-activated neuronal groups were elucidated using retrograde (cholera toxin-ß subunit, CTB) and anterograde (phaseolus vulgaris leucoagglutinin, PHA-L) tracers in male rats. C-Fos-immunoreactivity was used as marker of neuronal activation. The refeeding-activated input of the CEA primarily originated from the paraventricular thalamic, parasubthalamic and parabrachial nuclei. Few CTB-c-Fos double-labeled neurons were detected in the prefrontal cortex, lateral hypothalamic area, nucleus of the solitary tract (NTS) and the bed nuclei of the stria terminalis (BNST). Only few refeeding-activated proopiomelanocortin-producing neurons of the arcuate nucleus projected to the CEA. Anterograde tract tracing revealed a high density of PHAL-labeled axons contacted with refeeding-activated neurons in the BNST, lateral hypothalamic area, parasubthalamic, paraventricular thalamic and parabrachial nuclei and NTS; a low density of labeled axons was found in the paraventricular hypothalamic nucleus. Chemogenetic activation of the medial CEA (CEAm) inhibited food intake during the first hour of refeeding, while activation of lateral CEA had no effect. These data demonstrate the existence of reciprocal connections between the CEA and distinct refeeding-activated hypothalamic, thalamic and brainstem nuclei, suggesting the importance of short feedback loops in the regulation of satiety and importance of the CEAm in the regulation of food intake during refeeding.


Subject(s)
Brain Mapping , Central Amygdaloid Nucleus/cytology , Central Amygdaloid Nucleus/physiology , Neural Pathways/physiology , Neurons/physiology , Satiety Response/physiology , Analysis of Variance , Animals , Arcuate Nucleus of Hypothalamus/cytology , Arcuate Nucleus of Hypothalamus/physiology , Cholera Toxin/metabolism , ELAV-Like Protein 3/metabolism , Eating/physiology , Fasting/physiology , Feeding Behavior/physiology , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Male , Phytohemagglutinins/metabolism , Pro-Opiomelanocortin/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Rats , Rats, Wistar , Transduction, Genetic , Red Fluorescent Protein
15.
Mol Cells ; 40(4): 271-279, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28359144

ABSTRACT

Ran-binding protein family member, RanBP9 has been reported in various basic cellular mechanisms and neuropathological conditions including schizophrenia. Previous studies have reported that RanBP9 is highly expressed in the mammalian brain and retina; however, the role of RanBP9 in retinal development is largely unknown. Here, we present the novel and regulatory roles of RanBP9 in retinal development of a vertebrate animal model, zebrafish. Zebrafish embryos exhibited abundant expression of ranbp9 in developing brain tissues as well as in the developing retina. Yeast two-hybrid screening demonstrated the interaction of RanBP9 with Mind bomb, a component of Notch signaling involved in both neurogenesis and neural disease autism. The interaction is further substantiated by co-localization studies in cultured cells. Knockdown of ranbp9 resulted in retinal dysplasia with defective proliferation of retinal cells, downregulation of neuronal differentiation marker huC, elevation of neural proliferation marker her4, and alteration of cell cycle marker p57kip2. Expression of the Müller glial cell marker glutamine synthase was also affected in knockdown morphants. Our results suggest that Mind bomb-binding partner RanBP9 plays a role during retinal cell development of zebrafish embryogenesis.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Cytoskeletal Proteins/metabolism , Nuclear Proteins/metabolism , Retina/embryology , Ubiquitin-Protein Ligases/metabolism , Zebrafish Proteins/metabolism , Zebrafish/embryology , Adaptor Proteins, Signal Transducing/genetics , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/metabolism , Brain/cytology , Brain/embryology , Brain/metabolism , COS Cells , Cell Proliferation , Chlorocebus aethiops , Cyclin-Dependent Kinase Inhibitor p57/genetics , Cyclin-Dependent Kinase Inhibitor p57/metabolism , Cytoskeletal Proteins/genetics , Down-Regulation , ELAV-Like Protein 3/genetics , ELAV-Like Protein 3/metabolism , Ependymoglial Cells/physiology , Gene Knockdown Techniques , Neurogenesis/physiology , Nuclear Proteins/genetics , Retina/cytology , Retina/metabolism , Retinal Dysplasia/genetics , Two-Hybrid System Techniques , Ubiquitin-Protein Ligases/genetics , Zebrafish/genetics , Zebrafish/metabolism , Zebrafish Proteins/genetics
16.
J Neurophysiol ; 117(1): 365-375, 2017 01 01.
Article in English | MEDLINE | ID: mdl-27784805

ABSTRACT

Glia play key roles in the regulation of neurotransmission in the nervous system. Fluoroacetate (FA) is a metabolic poison widely used to study glial functions by disrupting the tricarboxylic acid cycle enzyme aconitase. Despite the widespread use of FA, the effects of FA on essential glial functions such as calcium (Ca2+) signaling and hemichannel function remain unknown. Therefore, our goal was to assess specifically the impact of FA on essential glial cell functions that are involved with neurotransmission in the enteric nervous system. To this end, we generated a new optogenetic mouse model to study specifically the effects of FA on enteric glial Ca2+ signaling by crossing PC::G5-tdTomato mice with Sox10::creERT2 mice. FA did not change the peak glial Ca2+ response when averaged across all glia within a ganglion. However, FA decreased the percent of responding glia by 30% (P < 0.05) and increased the peak Ca2+ response of the glial cells that still exhibited a response by 26% (P < 0.01). Disruption of Ca2+ signaling with FA impaired the activity-dependent uptake of ethidium bromide through connexin-43 (Cx43) hemichannels (P < 0.05) but did not affect baseline Cx43-dependent dye uptake. FA did not cause overt glial or neurodegeneration, but glial cells significantly increased glial fibrillary acid protein by 56% (P < 0.05) following treatment with FA. Together, these data show that the acute impairment of glial metabolism with FA causes key changes in glial functions associated with their roles in neurotransmission and phenotypic changes indicative of reactive gliosis. NEW & NOTEWORTHY: Our study shows that the acute impairment of enteric glial metabolism with fluoroacetate (FA) alters specific glial functions that are associated with the modification of neurotransmission in the gut. These include subtle changes to glial agonist-evoked calcium signaling, the subsequent disruption of connexin-43 hemichannels, and changes in protein expression that are consistent with a transition to reactive glia. These changes in glial function offer a mechanistic explanation for the effects of FA on peripheral neuronal networks.


Subject(s)
Calcium Signaling/drug effects , Connexin 43/metabolism , Fluoroacetates/pharmacology , Gene Expression Regulation/drug effects , Myenteric Plexus/cytology , Neuroglia/drug effects , Adenosine Diphosphate/pharmacology , Aniline Compounds/pharmacology , Animals , Cell Count , ELAV-Like Protein 3/metabolism , ELAV-Like Protein 4/metabolism , Female , Gene Expression Regulation/genetics , Glial Fibrillary Acidic Protein/genetics , Glial Fibrillary Acidic Protein/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , S100 Calcium Binding Protein beta Subunit/metabolism , SOXE Transcription Factors/genetics , SOXE Transcription Factors/metabolism , Xanthenes/pharmacology
17.
Hum Brain Mapp ; 38(2): 909-922, 2017 02.
Article in English | MEDLINE | ID: mdl-27726278

ABSTRACT

The subthalamic nucleus (STN) is a main target structure of deep brain stimulation (DBS) in idiopathic Parkinson's disease. Nevertheless, there is an ongoing discussion regarding human STN volumes and neuron count, which could potentially have an impact on STN-DBS. Moreover, a suspected functional subdivision forms the basis of the tripartite hypothesis, which has not yet been morphologically substantiated. In this study, it was aimed to investigate the human STN by means of combined magnetic resonance imaging (MRI) and stereology. STN volumes were obtained from 14 individuals (ranging from 65 to 96 years, 25 hemispheres) in 3 T MRI and in luxol-stained histology slices. Neuron number and cell densities were investigated stereologically over the entire STN and in pre-defined subregions in anti-human neuronal protein HuC/D-stained slices. STN volumes measured with MRI were smaller than in stereology but appeared to be highly consistent, measuring on average 99 ± 6 mm3 (MRI) and 132 ± 20 mm3 (stereology). The neuron count was 431,088 ± 72,172. Both STN volumes and cell count decreased age-dependently. Neuron density was different for the dorsal, medial and ventral subregion with significantly higher values ventrally than dorsally. Small variations in STN volumes in both MRI and stereology contradict previous findings of large variations in STN size. Age-dependent decreases in STN volumes and neuron numbers might influence the efficacy of STN-DBS in a geriatric population. Though the study is limited in sample size, site-dependent differences for the STN subregions form a morphological basis for the tripartite theory. Hum Brain Mapp 38:909-922, 2017. © 2016 Wiley Periodicals, Inc.


Subject(s)
Aging , Magnetic Resonance Imaging , Stereotaxic Techniques , Subthalamic Nucleus/cytology , Subthalamic Nucleus/diagnostic imaging , Aged , Aged, 80 and over , Cell Count , ELAV-Like Protein 3/metabolism , ELAV-Like Protein 4/metabolism , Female , Humans , Imaging, Three-Dimensional , Male , Neurons/metabolism
18.
Restor Neurol Neurosci ; 34(2): 325-35, 2016.
Article in English | MEDLINE | ID: mdl-26889968

ABSTRACT

PURPOSE: The aim of the study was to investigate the functional role of L1.2, the zebrafish paralog of L1.1 and ortholog of mammalian L1CAM in adult zebrafish spinal cord regeneration after injury. L1CAM and L1.1 have shown beneficial features in ameliorating nervous system dysfunctions in different experimental paradigms. It thus deemed important to characterize the L1.2 member of the L1CAM family, the functions of which are unknown. METHODS: Spinal cord transection of adult zebrafish, application of anti-sense morpholino to reduce L1.2 expression, qPCR, immunohistology, immunoblotting, in situ hybridization, retrograde tracing, anterograde tracing. RESULTS: Similar to L1.1, L1.2 expression in adult zebrafish is upregulated after spinal cord transection. By co-localization of in situ hybridization and immunohistology, L1.2 is expressed in neurons and, in contrast to L1.1, it is also expressed in GFAP-immunoreactive glia. Reducing L1.2 protein levels leads to impaired locomotor recovery and reduction of regrowth of severed descending axons from a brain stem nucleus which is composed of neurons innately capable of axonal regrowth. CONCLUSIONS: Our findings support the speculation that paralogs of duplicated genes can exert similar functions and may thus represent an advantage over other species that do not carry duplicated genes.


Subject(s)
Neural Cell Adhesion Molecule L1/metabolism , Recovery of Function/physiology , Spinal Cord Injuries/physiopathology , Spinal Cord Regeneration/physiology , Up-Regulation/physiology , Analysis of Variance , Animals , Axons/drug effects , Axons/metabolism , Disease Models, Animal , ELAV-Like Protein 3/metabolism , Glial Fibrillary Acidic Protein/metabolism , LIM-Homeodomain Proteins/genetics , LIM-Homeodomain Proteins/metabolism , Locomotion/drug effects , Lysine/analogs & derivatives , Lysine/metabolism , Morpholinos/pharmacology , Neural Cell Adhesion Molecule L1/genetics , RNA, Messenger/metabolism , Recovery of Function/drug effects , Spinal Cord Injuries/metabolism , Swimming/physiology , Transcription Factors/genetics , Transcription Factors/metabolism , Up-Regulation/drug effects , Zebrafish
19.
Behav Brain Res ; 304: 125-38, 2016 May 01.
Article in English | MEDLINE | ID: mdl-26778786

ABSTRACT

Embryonic exposure to ethanol is known to affect neurochemical systems in rodents and increase alcohol drinking and related behaviors in humans and rodents. With zebrafish emerging as a powerful tool for uncovering neural mechanisms of numerous diseases and exhibiting similarities to rodents, the present report building on our rat studies examined in zebrafish the effects of embryonic ethanol exposure on hypothalamic neurogenesis, expression of orexigenic neuropeptides, and voluntary ethanol consumption and locomotor behaviors in larval and adult zebrafish, and also effects of central neuropeptide injections on these behaviors affected by ethanol. At 24h post-fertilization, zebrafish embryos were exposed for 2h to ethanol, at low concentrations of 0.25% and 0.5%, in the tank water. Embryonic ethanol compared to control dose-dependently increased hypothalamic neurogenesis and the proliferation and expression of the orexigenic peptides, galanin (GAL) and orexin (OX), in the anterior hypothalamus. These changes in hypothalamic peptide neurons were accompanied by an increase in voluntary consumption of 10% ethanol-gelatin and in novelty-induced locomotor and exploratory behavior in adult zebrafish and locomotor activity in larvae. After intracerebroventricular injection, these peptides compared to vehicle had specific effects on these behaviors altered by ethanol, with GAL stimulating consumption of 10% ethanol-gelatin more than plain gelatin food and OX stimulating novelty-induced locomotor behavior while increasing intake of food and ethanol equally. These results, similar to those obtained in rats, suggest that the ethanol-induced increase in genesis and expression of these hypothalamic peptide neurons contribute to the behavioral changes induced by embryonic exposure to ethanol.


Subject(s)
Central Nervous System Depressants/pharmacology , Embryo, Nonmammalian/drug effects , Ethanol/pharmacology , Gene Expression Regulation/drug effects , Hypothalamus , Neuropeptides/metabolism , Age Factors , Alcohol Drinking/pathology , Analysis of Variance , Animals , Bromodeoxyuridine/metabolism , ELAV-Like Protein 3/metabolism , ELAV-Like Protein 4/metabolism , Female , Galanin/genetics , Galanin/metabolism , Hypothalamus/drug effects , Hypothalamus/embryology , Hypothalamus/growth & development , Larva , Neurogenesis/drug effects , Neuropeptides/genetics , Neuropeptides/pharmacology , Orexins/genetics , Orexins/metabolism , Pregnancy , Zebrafish
20.
Int J Dev Neurosci ; 48: 9-17, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26562178

ABSTRACT

BCL-2 is a multifunctional protein involved in the regulation of apoptosis, cell cycle progression and neural developmental processes. Its function in the latter process is not well understood and needs further elucidation. Therefore, we characterized the protein expression kinetics of BCL-2 and associated regulatory proteins of the intrinsic apoptosis pathway during the process of neuronal differentiation in ReNcell VM cells with and without functional inhibition of BCL-2 by its competitive ligand HA14-1. Inhibition of BCL-2 caused a diminished BCL-2 expression and higher levels of cleaved BAX, activated Caspase-3 and cleaved PARP, all pro-apoptotic markers, when compared with untreated differentiating cells. In parallel, flow cytometric analysis of HA14-1-treated cells revealed a delayed differentiation into HuC/D+ neuronal cells when compared to untreated differentiating cells. In conclusion, BCL-2 possess a protective function in fully differentiated ReNcell VM cells. We propose that the pro-survival signaling of BCL-2 is closely connected with its stimulatory effects on neurogenesis of human neural progenitor cells.


Subject(s)
Apoptosis/physiology , Cell Differentiation/physiology , Neurons/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Apoptosis/drug effects , Benzopyrans/pharmacology , Cell Differentiation/drug effects , Cell Line, Transformed , ELAV-Like Protein 3/metabolism , ELAV-Like Protein 4/metabolism , Enzyme Inhibitors/pharmacology , Flow Cytometry , Gene Expression Regulation/drug effects , Humans , Mitochondrial Membranes/metabolism , Neurons/drug effects , Nitriles/pharmacology , Time Factors , bcl-2-Associated X Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...